Menu Close

Articles on Hepatitis C

Displaying 1 - 20 of 58 articles

Imaging the proteins on the surface of HCV has been challenging because of the virus’s shape-shifting nature. Juan Gaertner/Science Photo Library via Getty Images

Scientists uncovered the structure of the key protein for a future hepatitis C vaccine – here’s how they did it

Using a Nobel Prize-winning technique called cryo-EM, researchers were able to identify potential areas on the hepatitis C virus that a vaccine could target.
Shutterstock

Direct-acting antivirals can cure hepatitis C and prisons are now leading efforts to eliminate the virus

Direct-acting antivirals can cure hepatitis C in eight to 12 weeks. But while the rate of uptake in Australia has slowed, a greater proportion of those undertaking treatment are in prison.
While hepatitis B can’t be cured in the same way hepatitis C can, effective treatment is available. From shutterstock.com

In contrast to Australia’s success with hepatitis C, our response to hepatitis B is lagging

Curing thousands of Australians with hepatitis C is one of the public health success stories of recent years. We can take lessons from this as we continue in the fight against hepatitis B.
Sen. Chuck Grassley, R-Iowa, chair of the Senate Finance Committee, prepares for the Feb. 26, 2019 hearing with CEOs from several U.S. drug makers. Pablo Martinez Monsivais/AP Photo

A new way to pay for innovative drugs, provide universal access and not break the bank

As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors. (Shutterstock)

Can you rely on the drugs that your doctor prescribes?

In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.

Top contributors

More